POSTERIOR SEGMENT EYE DISORDERS MARKET ANALYSIS

Posterior Segment Eye Disorders Market, By Product (Drugs and Devices), By Application (Macular Degeneration, Glaucoma, Diabetic Retinopathy, and Other Applications), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI5470
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Posterior Segment Eye Disorders Market: Key Companies Insights

The global posterior segment eye disorders market is highly competitive. This is attributed to the increase in burden of posterior segment eye disorders worldwide, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global posterior segment eye disorders market are Novartis AG, Merck & Co. Inc., F. Hoffmann-La Roche AG, AbbVie Inc (Allergan), Alcon Inc., Bausch Health Companies Inc., Aerie Pharmaceuticals, Santen Pharmaceutical Co. Ltd., Second Sight Medical Products Inc., Rainbow Medical Ltd (Nano Retina), and Regeneron Pharmaceuticals Inc.